- Home
- TSAT vs AQST Comparison
TSAT vs AQST Comparison
Compare TSAT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- AQST
- Stock Information
- Founded
- TSAT 1969
- AQST 2004
- Country
- TSAT Canada
- AQST United States
- Employees
- TSAT N/A
- AQST N/A
- Industry
- TSAT Metal Fabrications
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- AQST Health Care
- Exchange
- TSAT Nasdaq
- AQST Nasdaq
- Market Cap
- TSAT 233.1M
- AQST 272.9M
- IPO Year
- TSAT 1996
- AQST 2018
- Fundamental
- Price
- TSAT $25.02
- AQST $3.40
- Analyst Decision
- TSAT
- AQST Strong Buy
- Analyst Count
- TSAT 0
- AQST 6
- Target Price
- TSAT N/A
- AQST $10.67
- AVG Volume (30 Days)
- TSAT 140.9K
- AQST 1.6M
- Earning Date
- TSAT 08-13-2025
- AQST 08-05-2025
- Dividend Yield
- TSAT N/A
- AQST N/A
- EPS Growth
- TSAT N/A
- AQST N/A
- EPS
- TSAT N/A
- AQST N/A
- Revenue
- TSAT $372,642,710.00
- AQST $54,228,000.00
- Revenue This Year
- TSAT N/A
- AQST N/A
- Revenue Next Year
- TSAT N/A
- AQST $45.71
- P/E Ratio
- TSAT N/A
- AQST N/A
- Revenue Growth
- TSAT N/A
- AQST 5.29
- 52 Week Low
- TSAT $7.21
- AQST $2.12
- 52 Week High
- TSAT $26.07
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- TSAT 69.94
- AQST 58.21
- Support Level
- TSAT $22.35
- AQST $3.13
- Resistance Level
- TSAT $25.35
- AQST $3.33
- Average True Range (ATR)
- TSAT 1.81
- AQST 0.21
- MACD
- TSAT 0.50
- AQST -0.03
- Stochastic Oscillator
- TSAT 83.40
- AQST 46.94
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.